A Phase Ⅲ Clinical Study of SYS6010 in Combination With Osimertinib in Patients With Locally Advanced or Metastatic NSCLC
Clinical trial NCT07376382 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07376382
- Sponsor
- CSPC Megalith Biopharmaceutical Co.,Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2026-12-12
- Enrollment
- 680
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.